Beating the heart failure epidemic: can emerging cell therapies deliver what conventional approaches cannot?
Advances in mesenchymal stem cells, extracellular vesicles, CRISPR-based gene editing, and emerging precision medicine strategies including multi-omics profiling, machine learning-based patient stratification, and adaptive trial design are discussed.
Russell G. Saltzman, K. Asensi, Arnab Chakraborty et al.
· Expert Review of Cardiovascu... · 0 citations